Suppression of basic fibroblast growth factor-induced angiogenesis by a specific chymase inhibitor, BCEAB, through the chymase-angiotensin-dependent pathway in hamster sponge granulomas

British Journal of Pharmacology

Volumn 137, Issue 4, 2002, Pages 554-560

  Muramatsu, Michiko ^a   Yamada, Mayumi ^a   Takai, Shinji ^a   Miyazaki, Mizuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Angiogenesis; Angiotensin; bFGF; Chymase; Inhibitor; VEGF

Indexed keywords

4 [1 [[BIS(4 METHYL PHENYL)METHYL]CARBAMOYL] 3 (2 ETHOXYBENZYL) 4 OXO AZETIDINE 2 YLOXY]BENZOIC ACID; ANGIOGENESIS INHIBITOR; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BASIC FIBROBLAST GROWTH FACTOR; CANDESARTAN HEXETIL; CHYMASE; CHYMOSTATIN; HEMOGLOBIN; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; 4 (1 ((BIS(4 METHYLPHENYL)METHYL)CARBAMOYL) 3 (2 ETHOXYBENZYL) 4 OXOAZETIDINE 2 YLOXY)BENZOIC ACID; 4-(1-((BIS(4-METHYLPHENYL)METHYL)CARBAMOYL)-3-(2-ETHOXYBENZYL)-4-OXOAZETIDINE-2-YLOXY)BENZOIC ACID; ANGIOTENSIN DERIVATIVE; AZETIDINE DERIVATIVE; BENZOIC ACID DERIVATIVE; ENZYME INHIBITOR; FIBROBLAST GROWTH FACTOR 2; SERINE PROTEINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOWMETRY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; GRANULOMA; HAMSTER; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG POTENTIATION; ENZYMOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SURGICAL SPONGE; SYRIAN HAMSTER;

ANGIOTENSINS; ANIMALS; AZETIDINES; BENZOIC ACIDS; CHYMASES; CRICETINAE; DRUG SYNERGISM; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTOR 2; GRANULOMA; MALE; MESOCRICETUS; NEOVASCULARIZATION, PATHOLOGIC; SERINE ENDOPEPTIDASES; SURGICAL SPONGES;

EID: 0036800652     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704893     Document Type: Article

References (40)

1. Blair, R.J., Meng, H., Marchese, M.J., Ren, S., Schwartz, L.B., Tonnesen, M.G. & Gruber, B.L. (1997). Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J. Clin. Invest., 99, 2691-2700.
2. Chua, C.C., Hamdy, R.C. & Chua, B. (1998). Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim. Biophys. Acta., 1401, 187-194.
3. Colville-Nash, P.R. & Scott, D.L. (1992). Angiogenesis and rheumatoid arthritis: Pathogenic and therapeutic implication. Ann. Rheum. Dis., 51, 919-925.
4. Emanueli, C., Salis, M.B., Stacca, T., Pinna, A., Gaspa, L. & Maddeddu, P. (2002). Angiotensin AT(l) receptor signaling modulates reparative angiogenesis induced by limb ischaemia. Br. J. Pharmacol., 135, 87-92.
5. Fan, T.P.D. & Brem, S. (1992). The search for anti-cancer drugs. In Cancer Biology and Medicine Series. Ed. Waring, M.J. & Ponder, B.A.J. pp. 185-229. Dordrecht: Kluwer Academic Publishing.
6. 92 bonds of the catalytic domain. J. Biol. Chem., 272, 25628-25635.
7. Fernandez, L.A., Twickler, J. & Mead, A. (1985). Neovascularization produced by angiotensin II. J. Lab. Clin. Med., 105, 141-145.
8. Folkman, J. (1971). Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med., 285, 1182-1186.
9. Folkman, J. & Shing, Y. (1992). Angiogenesis. J. Biol. Chem., 267, 10931-10934.
10. Gruber, B.L., Marchese, M.J. & Kew, R. (1995). Angiogenic factors stimulate mast-cell migration. Blood, 86, 2488-2493.
11. Hata, Y., Rook, S. & Aiello, L.P. (1999). Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway. Diabetes, 48, 1145-1155.
12. Hikichi, T., Mori, F., Takamiya, A., Sasaki, M., Horikawa, Y., Takeda, M. & Yoshida, A. (2001). Inhibitory effects of losartan on laser-induced choroidal neovascularization. Am. J. Ophthalmol., 132, 587-589.
13. Itoh, H., Mukoyama, M., Pratt, R.E., Gibbons, G.H. & Dzau, V.J. (1993). Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J. Clin. Invest., 9, 2268-2274.
14. Jin, D., Takai, S., Yamada, M., Sakaguchi, M., Yao, Y. & Miyazaki, M. (2001). Possible roles of cardiac chymase after myocardial infarction in hamster hearts. Jpn. J. Pharmacol., 86, 203-214.
15. Jin, D., Takai, S., Yamada, M., Sakaguchi, M. & Miyazaki, M. (2002). Beneficial effects of cardiac chymase inhibition during the acute phase of myocardial infarction. Life Science, 71, 437-446.
16. Langunoff, D. & Benditt, E.P. (1963). Proteolytic enzymes of mast cells. Ann. N.Y. Acad. Sci., 103, 185-198.
17. Le Noble, F.A.C., Hekking, J.W.M., Van Straaten, H.W.M., Slaaf, D.W. & Boudier, H.A.J.S. (1991). Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur. J. Pharmacol., 195, 305-306.
18. Lindstedt, K.A., Wang, Y., Shiota, N., Saarinen, J., Hyytiainen, M., Kokkonen, J.O., Keski-Oja, J. & Kovanen, P.T. (2001). Activation of paracrine TGF-β1 signaling upon stimulation and degranulation of rat serosal mast cells: A novel function for chymase. FASEB J., 15, 1377-1388.
19. Majima, M., Isono, M., Ikeda, Y., Hayashi, I., Hatanaka, K., Harada, Y., Katsumata, O., Yamashina, S. & Katori, M. (1997). Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants. Jpn. J. Pharmacol., 75, 105-114.
20. Michaelson, I.C. (1948). The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans. Ophthalmol. U.K., 68, 137-180.
21. Mizutani, H., Schechter, N., Lazarus, G., Black, R.A. & Kupper, T.S. (1991). Rapid and specific conversion of precursor interleukin lfl (IL-1β) to an active IL-1 species by human mast cell chymase. J. Exp. Med., 174, 821-825.
22. Muramatsu, M., Katada, J., Hayashi, I. & Majima, M. (2000a). Chymase as a proangiogenic factor; a possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model. J. Biol. Chem., 275, 5545-5552.
23. Muramatsu, M., Katada, J., Hattori, M., Hayashi, I. & Majima, M. (2000b). Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas. Eur. J. Pharmacol., 402, 181-191.
24. Okamura, K., Sato, Y., Matsuda, T., Hamanaka, R., Ono, M., Kohno, K. & Kuwano, M.. (1991). Endogenous basic fibroblast growth factor-dependent induction of collagenase and interleukin-6 in tumor necrosis factor treated human microvascular endothelial cells. J. Biol. Chem. 266, 19162-19165.
25. Okunishi, H., Oka, Y., Shiota, N., Kawamoto, T., Song, K. & Miyazaki, M. (1993). Marked species-difference in the vascular angiotensin II-forming pathways: Humans versus rodents. Jpn. J. Pharmacol., 62, 207-210.
26. Okunishi, H., Miyazaki, M. & Toda, N. (1984). Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J. Hypertens., 2, 277-284.
27. O'reilly, M.S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R.A., Moses, M., Lane, W.S., Cao, Y., Sage, E.H. & Folkman, J. (1994). Angiostatis: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79, 315-328.
28. Otani, A., Takagi, H., Oh, H., Suzuma, K., Matsumura, M., Ikeda, E. & Honda, Y. (2000). Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericyte. Invest. Ophthalmol. Vis. Sci., 41, 1192-1199.
29. Peacock, D.J., Banquerigo, M.L. & Brahn, E. (1992). Angiogenesis inhibition suppresses collagen arthritis. J. Exp. Med., 175, 1135-1138.
30. Peifley, K.A. & Winkles, J.A. (1998). Angiotensin II and endothelin-1 increase fibroblasts growth factor-2 mRNA expression in vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 242, 202-208.
31. Pupilli, C., Lasagni, L., Romagnani, P., Bellini, F., Mannelli, M., Misciglia, N., Mavillia, C., Vellei, U., Villari, D. & Serio, M. (1999). Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. J. Am. Soc. Nephrol., 10, 245-255.
32. Relf, M., Lejeune, S., Scott, P.A., Fox, S., Smith, K., Leek, R., Moghaddam, A., Whitehouse, R., Bicknell, R. & Harris, A.L. (1997). Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, transforming growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res., 57, 963-969.
33. Sasaki, K., Murohara, T., Ikeda, H., Sugaya, T., Shimada, T., Shintani, S. & Imaizumi, T. (2002). Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J. Clin. Invest., 109, 603-611.
34. Taipale, J., Lohi, J., Saarine, J., Kovanen, P.T. & Keski-Oja, J. (1995). Human mast cell chymase and leukocyte elastase release latent transforming growth factor-β from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem., 270, 4689-4696.
35. Takai, S., Yuda, A., Jin, D., Nishimoto, M., Sakaguchi, M., Sasaki, S. & Miyazaki, M. (2000). Inhibition of chymase reduces vascular proliferation in dog grafted veins. FEBS Lett., 467, 141-144.
36. Takai, S., Jin, D., Sakaguchi, M., Kirimura, K. & Miyazaki, M. (2001). An orally active chymase inhibitor, BCEAB, suppresses heart chymase activity in the hamster. Jpn. J. Pharmacol., 86, 124-126.
37. Tamarat, R., Silvestre, J.S., Kubis, N., Benessiano, J., Duriez, M., Degasparo, M., Henrion, D. & Levy, B.I. (2002). Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Hypertension, 39, 830-835.
38. Tille, J.C., Wood, J., Mandriota, S.J., Schnell, C., Ferrari, S., Mestan, J., Zhu, Z., Witte, K. & Pepper, M.S. (2001). Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro. J. Pharmacol. Exp. Ther., 299, 1073.
39. Walsh, D.A., Hu, D.E., Wharton, J., Catravas, J.D., Blake, D.R. & Fan, T.P. (1997). Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma. Br. J. Pharmacol., 120, 1302-1311.
40. Wise, G.N. (1956). Retinal neovascularization. Trans. Am. Ophthalmol. Soc., 54, 729-826.